Company Filing History:
Years Active: 2022
Title: Paul Blaney - Innovator in Pharmaceutical Chemistry
Introduction
Paul Blaney is a notable inventor based in Derbyshire, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on hydroxynorketamine. His research focuses on developing stable and processable salt forms of this compound, which has implications for medical applications.
Latest Patents
Paul Blaney holds a patent for "Crystalline forms of hydroxynorketamine." This invention provides novel, stable, processable, and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamine or 2S,6S-hydroxynorketamine with high aqueous solubility. This advancement is crucial for enhancing the efficacy and delivery of the compound in therapeutic settings.
Career Highlights
Throughout his career, Paul has been associated with Small Pharma Ltd., where he has played a pivotal role in advancing pharmaceutical innovations. His expertise in the field has led to the development of new formulations that can improve patient outcomes.
Collaborations
Paul collaborates with talented professionals such as David Pearson and Lorraine Sharp. Their combined efforts contribute to the ongoing research and development initiatives at Small Pharma Ltd.
Conclusion
Paul Blaney's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the area of hydroxynorketamine, highlight the importance of research and development in creating effective medical solutions.